
Loading, please wait...

Loading, please wait...
"Wherever the art of Medicine is loved, there is also a love of Humanity."
Hippocrates

A recent study highlights a rising metabolic health risk among young adults in urban India. Consequently, healthcare providers must adopt a proactive screening approach. Specifically, researchers found that more than 50 per cent of millennials in Delhi-NCR are overweight or obese. This troubling trend underscores the urgent need for early interventions before chronic conditions manifest.
Pacific OneHealth Hospitals conducted a study involving 4,000 individuals across Delhi-NCR. Surprisingly, researchers observed a sharp escalation in obesity and hypertension with age. Among Gen Z participants, only 8.5 per cent showed elevated visceral fat. However, this metric surged to 27.6 per cent in millennials. Ultimately, it reached a staggering 70.8 per cent in adults aged 45 and older.
The researchers identified the 30-44 age group as the most critical intervention window. During this phase, visceral fat accumulation rises sharply. Therefore, this age range creates the foundation for future hypertension, diabetes, and cardiovascular diseases. Moreover, a dramatic jump in hypertension occurred after age 45, rising from 7.3 per cent in millennials to 46.9 per cent in older cohorts. This represents an alarming 6.4-fold increase.
According to Dr. Swadeep Srivastava, Co-Founder of Pacific OneHealth Hospitals, the current healthcare system reacts too late. It engages patients only after diseases manifest. Thus, the future of healthcare must prioritize proactive risk detection and personalized wellness planning. Additionally, reverting metabolic consequences becomes extremely difficult and expensive after age 45.
Q1: What are the primary findings of the Pacific OneHealth study regarding millennials?
The study found that more than 50 per cent of millennials in the Delhi-NCR region are overweight or obese. Additionally, visceral fat levels and hypertension show a sharp escalation as individuals age.
Q2: Why is the age group of 30 to 44 considered critical for metabolic health?
This age range represents a crucial intervention window because obesity and visceral fat accumulation rise sharply during this period. Consequently, these changes establish the groundwork for future cardiovascular diseases, diabetes, and hypertension.
Q3: How does hypertension prevalence change after age 45 according to the study?
The study showed a dramatic 6.4-fold jump in hypertension. Specifically, prevalence rates increase from 7.3 per cent among millennials to 46.9 per cent among Gen X and older cohorts.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

A new study by Pacific OneHealth Hospitals reveals that over 50% of millennials in Delhi-NCR are overweight or obese. It highlights a critical metabolic health risk window between ages 30 and 44, during which visceral fat accumulation and hypertension rise sharply, driving future cardiovascular diseases.
Yesterday

With experts warning of an El Niño-induced rise in monsoon infections, Maharashtra has ordered intensive disease surveillance and preventative actions. Healthcare systems are enhancing laboratory resources and monitoring larval sources to control mosquito-borne outbreaks like dengue and chikungunya.
Today

A study confirms that short-course preoperative endocrine therapy significantly reduces Ki67 levels in ER-positive breast cancer, with the MammaPrint assay acting as a key predictor of this functional response.
Today

Researchers have developed a recyclable, high-strength chitosan-based conductive hydrogel. It enables high-fidelity monitoring of ECG, EMG, and EEG signals, offering a sustainable and sensitive solution for early-stage disease screening and multifunctional human motion sensing.
Today

Restoring load-bearing connective tissues remains a challenge in regenerative medicine. This review explores how biomass-derived hydrogels, enhanced by AI and innovative reinforcement strategies, are paving the way for next-generation clinical scaffolds in orthopedics and surgery.
Today

Researchers have developed a modular PEG-based scaffold that simplifies the creation of multi-agonist peptide therapeutics. Using GLP-1 and amylin agonists as a model, this platform enables rapid, modular assembly of potent multi-receptor drugs, offering a new route for treating obesity and metabolic diseases.
Today